October is Raynaud’s Awareness Month. It is also the month when the beautiful autumnal shades over here in the U.K. remind me that my winter “full-time hibernation” is looming.

My 50 shades of blue “party trick,” where my hands and feet change color at the slightest temperature decrease, is extremely difficult to control at this time of year.

I have detailed my Raynaud’s challenges, highlighting the immense impact this diagnosis has on my life, combined with the full-time job of managing scleroderma symptoms.

My “Tin Man” body, along with fatigue and mobility challenges, remain constant sources of frustration.

“Ah great, another day to spend in bed” is not my favorite mantra.

People kindly say, “But you look so well.” But the reality is Raynaud’s symptoms keep me under “house arrest” year-round. My Raynaud’s sensitivity is so severe that an attack can be induced by me just moving from one room to another — indoors! Therefore, my symptoms are easiest managed by avoiding any temperature change.

My inner “Bond Girl” absconded years ago, leaving me wearing Ugg boots and gloves, even in the summer.

There is currently no cure for Raynaud’s, and prescription medications create blood pressure-altering, unpleasant, side effects. I no longer experience as many digital ulcers and the intense, excruciating pain which comes with them, since taking bosentan (125 mg) twice a day.

A trailblazer, Dr. Kevin Howell at the Royal Free Hospital, has kindly shared a video explaining the science behind what happens during a Raynaud’s episode.

Nailfold capillaroscopy is a diagnostic test used to identify possible blood vessel damage, which can indicate a possible underlying autoimmune condition. The nailfold capillaroscopy equipment costs around £1,500.

Without a shadow of a doubt, the entire global Raynaud’s community is eternally grateful to Dr. Howell for his dedication and commitment to the Raynaud’s enigma over the course of his career within the U.K.’s National Health Service (NHS). He is currently celebrating his 26th year in the NHS.

Many congratulations and thank you, Dr. Howell, the global Raynaud’s trailblazer.

October is a very busy month for our community, providing lots of awareness platform opportunities.

Invisible Disabilities Week takes place from Oct. 14 to 20.

Oct. 12 is the anniversary of the passing of a late scleroderma and Raynaud’s trailblazer, Anne Mawdsley.

I am eternally grateful for Anne’s friendship and all she has done to give our community a voice over the last few decades.

Anne’s contribution was recognized within a poster, “Optimizing Scleroderma Centers of Excellence: Perspectives from Patients and Systemic Sclerosis (SSc) Experts,” presented at the 2016 Systemic Sclerosis World Congress held in Lisbon. An acknowledgment was “dedicated to the memory of Anne, founder of the Raynaud’s and Scleroderma Association U.K., who raised over 10 million pounds for SSc research, education and advocacy in her lifetime.” The poster is found in the Journal of Scleroderma and Related Disorders.

During my global patient profiles campaign for Scleroderma Awareness Month 2017 and 2018, every patient detailed how Raynaud’s and digital ulcers were a continual problem.

Other unmet clinical needs that patients have in common include:

I am honored to be a patient research ambassador with the National Institute for Health Research.

Overall, for optimum patient care, three hallmarks preside:

In the meantime, I continue to remind myself that “my job today is to simply get better,” with hope and my canine diva dream team as my constant companions.

Living the dream, scleroderma style.

Facebook Page: Raynauds Scleroderma Awareness Global Patients

Twitter: @SclerodermaRF @RaynaudsRf

Google Plus: RaynaudsSclerodermaAwarenessGlobalPatients

#SclerodermaFreeWorld #RaynaudsFreeWorld

Please donate to help fund medical research at the Raynaud’s Unit in The Royal Free Hospital, London. Click here to donate to the Scleroderma Unit.

***

Note: Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Scleroderma News or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to scleroderma.